PSYCHOPHARMACOLOGY OF MOOD DISORDER IN PERSONS WITH MENTAL RETARDATION AND AUTISM
Kaydedildi:
HELLINGS, J.A., PSYCHOPHARMACOLOGY OF MOOD DISORDER IN PERSONS WITH MENTAL RETARDATION AND AUTISM. MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS, Vol. 5, no. 4 (1999), p. 270-278.
Ref.
83240
Yer:
SIIS R.1376
Palabras clave:
Autismo, Discapacidad del lenguaje, Discapacidad intelectual, Efectos, Efectos no deseados, Fármacos, Trastornos del espectro autista, Trastornos psicológicos, Tratamiento
Autismo, Discapacidad del lenguaje, Discapacidad intelectual, Efectos, Efectos no deseados, Fármacos, Trastornos del espectro autista, Trastornos psicológicos, Tratamiento
Benzer Materyaller: PSYCHOPHARMACOLOGY OF MOOD DISORDER IN PERSONS WITH MENTAL RETARDATION AND AUTISM
- ATYPICAL ANTIPSYCHOTICS IN PERSONS WITH DEVELOPMENTAL DISABILITIES
- MATERNAL RECURRENT MOOD DISORDERS AND HIGH FUNCTIONING AUTISM
- CHARACTERISTICS ASSOCIATED WITH PRESENCE OF DEPRESSIVE SYMPTOMS IN ADULTS WITH AUTISM SPECTRUM DISORDER
- PSYCHOPHARMACOLOGY IN CHILD AND ADOLESCENT PSYCHIATRY: A REVIEW OF THE PAST FIVE YEARS
- THE PDD-MRS. AN INSTRUMENT FOR IDENTIFICATION OF AUTISM SPECTRUM DISORDERS IN PERSONS WITH MENTAL RETARDATION
- MULTI-INFORMANT RATINGS OF PSYCHIATRIC SYMPTOM SEVERITY IN CHILDREN WITH AUTISM SPECTRUM DISORDERS: THE IMPORTANCE OF ENVIRONMENTAL CONTEXT